Skye Bioscience (SKYE) Balance Sheet: Assets & Liabilities

Skye Bioscience (SKYE) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Skye Bioscience reported total assets of $28.31M and total liabilities of $8.29M. Shareholders' equity was $20.02M, down 70.6% from $68.15M a year earlier. Total debt stood at $273.65K against $25.74M in cash and short-term investments, a net cash position of $25.46M. That puts debt-to-equity at 0.01, compared with 0.01 a year earlier.

Skye Bioscience Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Skye Bioscience, Inc. (SKYE) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018	Dec 2017
Current Assets
Cash and Cash Equivalents	5.88	68.42	1.26	1.24	8.98	2.47	1.83	1.85	0.26
Short-Term Investments	19.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	25.74	68.42	1.26	1.24	8.98	2.47	1.83	1.85	0.26
Accounts Receivable	0.01	0.01	0.70	0.07	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	0.01	2.41	10.39	7.63	0.63	0.19	0.16	0.10	0.30
Total Current Assets	27.09	70.83	11.65	8.94	9.61	2.66	1.99	1.95	0.56
Non-Current Assets
Property, Plant & Equipment (Net)	1.17	1.88	0.28	0.16	0.23	0.01	0.00	0.00	0.00
Other Non-Current Assets	0.05	0.05	0.01	0.01	0.01	0.00	0.00	0.00	0.00
Total Non-Current Assets	1.22	1.94	0.29	0.17	0.24	0.01	0.00	0.00	0.00
Total Assets	28.31	72.76	11.94	9.11	9.86	2.67	2.00	1.96	0.56
Current Liabilities
Accounts Payable	2.03	0.57	0.96	1.79	0.90	0.36	0.14	0.02	0.10
Short-Term Debt	0.19	0.18	4.37	1.98	2.06	0.06	0.00	0.00	0.24
Current Portion of Long-Term Debt	-	-	-	1.85	1.97	0.06	-	-	-
Accrued Liabilities	3.35	3.04	1.25	0.67	0.52	0.32	-	-	-
Other Current Liabilities	2.63	3.59	7.25	8.34	0.95	0.04	0.83	15.92	0.47
Total Current Liabilities	8.21	4.34	13.90	12.12	3.91	0.79	0.97	15.94	0.81
Non-Current Liabilities
Long-Term Debt	0.08	0.27	0.17	0.00	0.08	1.43	0.39	1.36	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.09	0.22	0.55
Total Non-Current Liabilities	0.08	0.27	0.17	0.00	0.08	1.43	0.48	1.58	0.55
Total Liabilities	8.29	4.61	14.07	12.12	3.99	2.22	1.45	17.52	1.36
Stockholders' Equity
Common Stock	0.03	0.03	0.01	0.00	0.48	0.29	0.18	0.13	0.03
Retained Earnings	-186.87	-130.95	-104.38	-66.74	-47.26	-38.73	-32.17	-33.23	-14.03
Additional Paid-in Capital	206.87	199.07	102.24	63.73	52.64	38.90	32.54	17.53	10.43
Shares Outstanding	33.38	30.97	12.35	3.65	1.90	-	-	-	-
Total Stockholders' Equity	20.02	68.15	-2.13	-3.01	5.86	0.45	0.55	-15.56	-0.80
Total Liabilities & Equity	28.31	72.76	11.94	9.11	9.86	2.67	2.00	1.96	0.56

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Skye Bioscience Balance Sheet

How much debt does Skye Bioscience have?

Skye Bioscience had total debt of $273.65K as of Dec 31, 2025, against $25.74M in cash and short-term investments. Its debt-to-equity ratio was 0.01. Total debt was $455.59K a year earlier.

What are Skye Bioscience's total assets?

Skye Bioscience reported total assets of $28.31M as of Dec 31, 2025, down 61.1% from $72.76M a year earlier. Total liabilities were $8.29M.

What is Skye Bioscience's shareholders' equity?

Skye Bioscience's shareholders' equity was $20.02M as of Dec 31, 2025, or about $0.60 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition